Drug Shortage Report for KADIAN
Report ID | 140904 |
Drug Identification Number | 02242163 |
Brand name | KADIAN |
Common or Proper name | MORPHINE SULFATE |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | MORPHINE SULFATE |
Strength(s) | 10MG |
Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2021-08-25 |
Actual start date | 2021-07-12 |
Estimated end date | 2021-10-19 |
Actual end date | 2021-10-20 |
Shortage status | Resolved |
Updated date | 2021-10-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2021-10-26 | French | Compare |
v9 | 2021-10-26 | English | Compare |
v8 | 2021-07-28 | French | Compare |
v7 | 2021-07-28 | English | Compare |
v6 | 2021-07-28 | French | Compare |
v5 | 2021-07-28 | English | Compare |
v4 | 2021-07-21 | French | Compare |
v3 | 2021-07-21 | English | Compare |
v2 | 2021-06-15 | French | Compare |
v1 | 2021-06-15 | English | Compare |
Showing 1 to 10 of 10